DiscoverX BioMAP® Diversity PLUS Panel
Diversity PLUS Panel contains 12 human primary cell systems from multiple tissues that model human disease for predictive insight into drug efficacy and MOA…
These systems represent a broad range of human biology relevant to multiple therapeutic areas. Cells are cultured alone or as co-cultures and stimulated with a combination of factors to model the complex signaling networks associated with disease states. Compounds are analysed in each system to determine their phenotypic impact on physiologically relevant disease biology in terms of efficacy and safety.
The Diversity PLUS panel is ideal in drug discovery applications such as:
- Translational biology
- Phenotypic drug discovery
- Competitive analysis
- Comparison to standard of care
- Analyze novel mechanisms of action
- Biomarker discover
Downloads
Learn More
Click here to find out more via email
Related content from this organisation
Related topics
Assays, Drug Discovery Processes, Drug Targets, Informatics, Screening, Translational Science
Related organisations
DiscoverX Corporation
Is it possible to know what kind of ‘mild stimulation’ is used for T cell activation by TCR in BT system of BioMAP?